Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc., €169k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dwight Moxie: trading record in brief
All filings by Dwight Moxie on record concern Revance Therapeutics, Inc., in the capacity of senior executive. In total, 27 filings cover trades dated from 18 February 2020 to 6 February 2025.
On the market, this insider has only sold: 7 sales, €2.2M in total. Outside the open market, there are 17 share grants.
Most recently, on 6 February 2025, the filings show a transaction in Revance Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dwight Moxie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,815 shares@ US$3.6513.9% of flowCommon StockSEC:0000950170-25-015361:0
- 5,979 shares0Common StockSEC:0000950170-25-014823:0
- 3,269 shares@ US$5.3051.3% of flowCommon StockSEC:0001479290-24-000067:0
- 15,143 shares0Common StockSEC:0001479290-24-000053:0
- 90,000 shares0Common StockSEC:0001479290-24-000016:0
- 23,853 shares@ US$17.814132.6% of flowCommon StockSEC:0001479290-23-000102:0
- 19,346 shares0Common StockSEC:0001479290-23-000098:0
- 42,349 shares0Common StockSEC:0001479290-23-000076:0
- 7,330 shares@ US$30.6517.2% of flowCommon StockSEC:0001479290-23-000040:0
- 42,349 shares0Common StockSEC:0001479290-23-000037:0
- 11,000 shares@ US$27.072524.5% of flowCommon StockSEC:0001479290-22-000086:0
- 2,881 shares@ US$15.793.5% of flowCommon StockSEC:0001209191-22-019721:0
- 1,675 shares@ US$30.003.7% of flowCommon StockSEC:0001479290-21-000154:0
13 of 13 declarations
